Centerpiece of the agreement is the establishment of The Waters Centre for BioMedical Mass Spectrometry
MILFORD, Mass., April 15 /PRNewswire/ -- Waters Corporation (NYSE: WAT) and the University of Warwick, Coventry and Warwickshire, England, today signed a collaborative research agreement intended to support the growth, development and adoption of novel mass spectrometry (MS) technologies, including Waters(R) SYNAPT High Definition MS(TM) (HDMS(TM)) system. This agreement paves the way for research projects leading to meaningful impact for analysts using biomedical mass spectrometry, validated by peer-reviewed publications, presentations at international conferences and an outreach education program.
At the core of the collaborative agreement is the establishment of 'The Waters Centre for BioMedical Mass Spectrometry' at the University of Warwick, a center of excellence in state-of-the-art MS techniques. This center will offer scientists worldwide an accessible resource to enable the adoption of cutting edge LC/MS-based techniques in life science.
"I believe that this partnership between a proven technology leader and a leading research focused University will provide a platform for the development of many exciting new projects," said Prof. James Scrivens, Department of Biological Sciences, University of Warwick. "I look forward to being part of a team that delivers the benefits of our research to the wider community."
"The University of Warwick is consistently ranked amongst the top research universities, with an historic track record in biological mass spectrometry," said Brian Smith, Vice President, Mass Spectrometry Operations for the Waters Division. "However, this agreement is not based on reputation alone; it is based on a
'/>"/>
SOURCE Waters Corporation Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
Waters Corporation Continues to Meet Todays Challenges for Improved Laboratory Operations with New Products at Pittcon 20092.
USDA Boosts Food Safety Research with Purchase of Waters ACQUITY TQD System3.
XenoTech LLC Offers Drug Industry New Metabolite Profiling Services Following Acquisition of Waters Synapt HDMS System4.
Waters New ACQUITY UPLC Online Community Attracts More Than 1,200 Members in First Month5.
Waters Corporation Gives Boost to Clinical Research Programs at University of Sherbrooke Hospital6.
Waters Publishes Rapid and Specific Method of Detection for Melamine in Infant Formula and Liquid Milk, in Support of Chinas Ministry of Science and Technology7.
David H. Murdock Research Institute Taps Waters for Laboratory Technology8.
Waters Brings Advanced Laboratory Data Management to Microsofts BioIT Alliance9.
Silver Lake Research Unveils Watersafe(R) Well Water Test Kit10.
Rutgers University Cell and DNA Repository Adopts BioLife Solutions CryoStor(TM) as Standard Biopreservation Media11.
University of Maryland Announces Finalists for $75K Business Plan Competition